Stay updated with breaking news from Year Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MELBOURNE, Australia and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT, the "Company")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent
Quarterly Activity Report Q3 FY24 Highlights • Completion of enrolment in first trial of sozinibercept's Phase 3 pivotal program...
Xlife Sciences AG Key word Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23Apr2024 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely responsibl
Xlife Sciences AG / Key word: Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23-Apr-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The...
Brings extensive experience in retinal and ophthalmology diseases...